<DOC>
	<DOCNO>NCT02975076</DOCNO>
	<brief_summary>Agents sanchi widely use complementary medicine stroke China . Sanchitongshu new Chinese patent medicine extract sanchi strong anti-platelet activity agent sanchi . The investigator 's aim investigate synergistic action aspirin combine sanchitongshu capsule treatment patient minor ischemic stroke transient ischemic attack .</brief_summary>
	<brief_title>Sanchitongtshu Plus Asprine Minor Ischemic Stroke Transient Ischemic Attack : A Randomized Double-blind Study</brief_title>
	<detailed_description>Transient ischemic attack ( TIA ) acute minor ischemic stroke common often lead disable event . In China , approximately 3 million new stroke every year , approximately 30 % minor ischemic stroke . The incidence TIA China determine , basis incidence country , probably 2 million TIAs annually China . The risk another stroke occur TIA minor stroke high , approximately 10 20 % patient stroke within 3 month index event ; stroke occur within first 2 day . The role antiplatelet therapy secondary stroke prevention well established . As yet , aspirin antiplatelet agent study acute phase stroke , benefit modest . Clopidogrel High-Risk Patients Acute Nondisabling Cerebrovascular Events ( CHANCE ) trial show among patient high-risk TIA minor ischemic stroke initially see within 24 hour symptom onset , treatment clopidogrel plus aspirin 21 day , follow clopidogrel alone total 90 day , superior aspirin alone reduce risk subsequent stroke event . The combination clopidogrel aspirin cause hemorrhagic event patient population aspirin alone . The analytical result provide basis synergistical effect Aspirin clopidogrel inhibit platelet aggregation . However , long term use clopidogrel bring people financial burden patient less compliance medication . Therefore , investigator need explore new treatment effective , safe economic . Sanchi one widely use herbal medicine China ischemic stroke , panax notoginseng saponin ( PNS ) main active component . Previously lots clinical trial agent PNS ischemic stroke China positive result . Sanchitongshu capsule new Chinese patent medicine extract sanchi . 80 % ingredient sanchi-tongshu capsule panaxatriol saponin ( PTS ) 60 % PTS Rg1 strong anti-platelet activity PNS . PTS proven experiment phase III clinical trial antithrombosis effect mechanism inhibit platelet aggregation , decrease blood viscosity , strengthen activity fibrinolysis system , promote vascular endothelial NO releasing . More recent experimental study indicate anti-inflammatory neuroprotective effect PTS . Compared agent Sanchi , Sanchitongshu capsule contain high purity PTS Rg1 . Thus , Sanchitongshu capsule theoretically vigorous improve ischemic status ischemic stroke . Include , investigator investigate synergistic action aspirin combine sanchitongshu capsule treatment patient minor ischemic stroke transient ischemic attack .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Ischemic Attack , Transient</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>1. age 40 year 80 year 2. diagnosis acute minor ischemic stroke transient ischemic attack ; ability start study drug within 24 hour symptom onset , define point patient report longer normal condition . Acute minor stroke define score 3 less time randomization National Institutes Health Stroke Scale ( NIHSS ) . TIA define focal brain ischemia resolution symptom within 24 hour onset plus moderatetohigh risk stroke recurrence ( define scoreâ‰¥4 time randomization ABCD2 ) . All patient confirm brain CT MRI . 3 . Patients ability accept medicine rule research . 4 . Patients serious complication normal renal function liver function . 1. age young 40 old 80 2 . Patients need thrombolysis 3. hemorrhage ; condition , vascular malformation , tumor , abcess , major nonischemic brain disease 4. isolated sensory symptom ( e.g. , numbness ) , isolate visual change , isolate dizziness vertigo without evidence acute infarction baseline CT MRI head 5. score 2 modify Rankin scale ( score range 0 ( symptom ) 6 ( death ) ) immediately occurrence index ischemic stroke TIA , indicate moderate disability bad baseline 6 . TIA minor stroke cause angiography surgery 7. clear indication anticoagulation therapy ( presumed cardiac source embolus , atrial fibrillation prosthetic cardio valve ) 8. anticipated requirement longterm nonstudy antiplatelet drug non steroidal antiinflammatory drug affect platelet function 9. accompany severe disorder heart , liver , kidney 10. severe noncardiovascular coexist condition , life expectancy le 3 month . 11. history hemorrhage bleeding tendency system ( thrombocytopenic purpura ) 12. gastrointestinal bleeding major surgery within previous 3 month 13. plan probable revascularization ( angioplasty vascular surgery ) within 3 month after.Operation Interventional Therapy require discontinuation study drug 14 . Aspirin , clopidogrel notoginseng allergy 15. history alcoholism drug abuse past 12 month 16. pregnant lactate woman , woman childbearing age without take effective contraceptive measure 17. patient serious disease abnormal laboratory result unfavorable join research 18. patient receive investigational drug device 19. incomprehension character category research unable follow research plan</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Sanchitongshu</keyword>
	<keyword>Acute Minor Stroke</keyword>
	<keyword>Transient Ischemic Attack</keyword>
</DOC>